Hypersensitivity to Phosphodiesterase 3 Inhibition in Post-Traumatic Headache

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
To investigate whether cilostazol (phosphodiesterase 3 inhibitor) induces headache with migraine-like features in people with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (mTBI).
Epistemonikos ID: 4904a87bce7ffec7282fb98f74706a27335b964d
First added on: May 14, 2024